PubMed:10022904
Annnotations
PMID_GLOBAL
{"project":"PMID_GLOBAL","denotations":[{"id":"T1","span":{"begin":320,"end":325},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0005070"}],"text":"Activation of IkappaB kinase beta by protein kinase C isoforms.\nThe atypical protein kinase C (PKC) isotypes (lambda/iotaPKC and zetaPKC) have been shown to be critically involved in important cell functions such as proliferation and survival. Previous studies have demonstrated that the atypical PKCs are stimulated by tumor necrosis factor alpha (TNF-alpha) and are required for the activation of NF-kappaB by this cytokine through a mechanism that most probably involves the phosphorylation of IkappaB. The inability of these PKC isotypes to directly phosphorylate IkappaB led to the hypothesis that zetaPKC may use a putative IkappaB kinase to functionally inactivate IkappaB. Recently several groups have molecularly characterized and cloned two IkappaB kinases (IKKalpha and IKKbeta) which phosphorylate the residues in the IkappaB molecule that serve to target it for ubiquitination and degradation. In this study we have addressed the possibility that different PKCs may control NF-kappaB through the activation of the IKKs. We report here that alphaPKC as well as the atypical PKCs bind to the IKKs in vitro and in vivo. In addition, overexpression of zetaPKC positively modulates IKKbeta activity but not that of IKKalpha, whereas the transfection of a zetaPKC dominant negative mutant severely impairs the activation of IKKbeta but not IKKalpha in TNF-alpha-stimulated cells. We also show that cell stimulation with phorbol 12-myristate 13-acetate activates IKKbeta, which is entirely dependent on the activity of alphaPKC but not that of the atypical isoforms. In contrast, the inhibition of alphaPKC does not affect the activation of IKKbeta by TNF-alpha. Interestingly, recombinant active zetaPKC and alphaPKC are able to stimulate in vitro the activity of IKKbeta but not that of IKKalpha. In addition, evidence is presented here that recombinant zetaPKC directly phosphorylates IKKbeta in vitro, involving Ser177 and Ser181. Collectively, these results demonstrate a critical role for the PKC isoforms in the NF-kappaB pathway at the level of IKKbeta activation and IkappaB degradation."}
bionlp-st-gro-2013-development
{"project":"bionlp-st-gro-2013-development","denotations":[{"id":"T2","span":{"begin":14,"end":33},"obj":"Enzyme"},{"id":"T3","span":{"begin":37,"end":62},"obj":"Enzyme"},{"id":"T4","span":{"begin":68,"end":93},"obj":"Enzyme"},{"id":"T5","span":{"begin":95,"end":98},"obj":"Enzyme"},{"id":"T9","span":{"begin":288,"end":301},"obj":"Enzyme"},{"id":"T11","span":{"begin":320,"end":347},"obj":"Protein"},{"id":"T12","span":{"begin":349,"end":358},"obj":"Protein"},{"id":"T14","span":{"begin":399,"end":408},"obj":"Protein"},{"id":"T15","span":{"begin":417,"end":425},"obj":"Protein"},{"id":"T17","span":{"begin":497,"end":504},"obj":"Protein"},{"id":"T18","span":{"begin":529,"end":541},"obj":"Enzyme"},{"id":"T20","span":{"begin":568,"end":575},"obj":"Protein"},{"id":"T21","span":{"begin":603,"end":610},"obj":"Enzyme"},{"id":"T22","span":{"begin":630,"end":644},"obj":"Enzyme"},{"id":"T23","span":{"begin":672,"end":679},"obj":"Protein"},{"id":"T24","span":{"begin":751,"end":766},"obj":"Enzyme"},{"id":"T25","span":{"begin":768,"end":776},"obj":"Enzyme"},{"id":"T26","span":{"begin":781,"end":788},"obj":"Enzyme"},{"id":"T28","span":{"begin":814,"end":822},"obj":"AminoAcid"},{"id":"T29","span":{"begin":830,"end":846},"obj":"Protein"},{"id":"T30","span":{"begin":970,"end":974},"obj":"Enzyme"},{"id":"T32","span":{"begin":987,"end":996},"obj":"Protein"},{"id":"T34","span":{"begin":1027,"end":1031},"obj":"Enzyme"},{"id":"T35","span":{"begin":1053,"end":1061},"obj":"Enzyme"},{"id":"T36","span":{"begin":1077,"end":1090},"obj":"Enzyme"},{"id":"T38","span":{"begin":1103,"end":1107},"obj":"Enzyme"},{"id":"T39","span":{"begin":1161,"end":1168},"obj":"Enzyme"},{"id":"T41","span":{"begin":1190,"end":1197},"obj":"Enzyme"},{"id":"T42","span":{"begin":1223,"end":1231},"obj":"Enzyme"},{"id":"T43","span":{"begin":1263,"end":1270},"obj":"Enzyme"},{"id":"T45","span":{"begin":1331,"end":1338},"obj":"Enzyme"},{"id":"T46","span":{"begin":1347,"end":1355},"obj":"Enzyme"},{"id":"T47","span":{"begin":1359,"end":1368},"obj":"Protein"},{"id":"T48","span":{"begin":1380,"end":1385},"obj":"Cell"},{"id":"T49","span":{"begin":1405,"end":1409},"obj":"Cell"},{"id":"T51","span":{"begin":1469,"end":1476},"obj":"Enzyme"},{"id":"T52","span":{"begin":1525,"end":1533},"obj":"Enzyme"},{"id":"T54","span":{"begin":1604,"end":1612},"obj":"Enzyme"},{"id":"T56","span":{"begin":1647,"end":1654},"obj":"Enzyme"},{"id":"T57","span":{"begin":1658,"end":1667},"obj":"Protein"},{"id":"T58","span":{"begin":1703,"end":1710},"obj":"Enzyme"},{"id":"T59","span":{"begin":1715,"end":1723},"obj":"Enzyme"},{"id":"T60","span":{"begin":1771,"end":1778},"obj":"Enzyme"},{"id":"T61","span":{"begin":1795,"end":1803},"obj":"Enzyme"},{"id":"T62","span":{"begin":1862,"end":1869},"obj":"Enzyme"},{"id":"T64","span":{"begin":1894,"end":1901},"obj":"Enzyme"},{"id":"T65","span":{"begin":2005,"end":2017},"obj":"Enzyme"},{"id":"T66","span":{"begin":2025,"end":2034},"obj":"Protein"},{"id":"T67","span":{"begin":2059,"end":2066},"obj":"Enzyme"},{"id":"T69","span":{"begin":2082,"end":2089},"obj":"Protein"},{"id":"T6","span":{"begin":110,"end":124},"obj":"Enzyme"},{"id":"T71","span":{"begin":129,"end":136},"obj":"Enzyme"},{"id":"T73","span":{"begin":740,"end":746},"obj":"ExperimentalMethod"},{"id":"T77","span":{"begin":1245,"end":1257},"obj":"ExperimentalMethod"},{"id":"T80","span":{"begin":1427,"end":1458},"obj":"Chemical"},{"id":"E1","span":{"begin":0,"end":10},"obj":"PositiveRegulation"},{"id":"E2","span":{"begin":216,"end":229},"obj":"CellGrowth"},{"id":"E3","span":{"begin":234,"end":242},"obj":"Maintenance"},{"id":"E4","span":{"begin":306,"end":316},"obj":"PositiveRegulation"},{"id":"E5","span":{"begin":385,"end":395},"obj":"PositiveRegulation"},{"id":"E6","span":{"begin":478,"end":493},"obj":"Phosphorylation"},{"id":"E7","span":{"begin":554,"end":567},"obj":"Phosphorylation"},{"id":"E8","span":{"begin":796,"end":809},"obj":"Phosphorylation"},{"id":"E9","span":{"begin":979,"end":986},"obj":"RegulatoryProcess"},{"id":"E10","span":{"begin":1009,"end":1019},"obj":"PositiveRegulation"},{"id":"E11","span":{"begin":1091,"end":1095},"obj":"BindingToProtein"},{"id":"E12","span":{"begin":1169,"end":1189},"obj":"PositiveRegulation"},{"id":"E13","span":{"begin":1317,"end":1327},"obj":"PositiveRegulation"},{"id":"E14","span":{"begin":1459,"end":1468},"obj":"PositiveRegulation"},{"id":"E15","span":{"begin":1590,"end":1600},"obj":"NegativeRegulation"},{"id":"E16","span":{"begin":1633,"end":1643},"obj":"PositiveRegulation"},{"id":"E17","span":{"begin":1879,"end":1893},"obj":"Phosphorylation"},{"id":"E18","span":{"begin":2067,"end":2077},"obj":"PositiveRegulation"},{"id":"E19","span":{"begin":2090,"end":2101},"obj":"ProteinCatabolism"},{"id":"E20","span":{"begin":661,"end":671},"obj":"NegativeRegulation"},{"id":"E21","span":{"begin":875,"end":889},"obj":"ProteinModification"},{"id":"E22","span":{"begin":894,"end":905},"obj":"ProteinCatabolism"},{"id":"E23","span":{"begin":1143,"end":1157},"obj":"PositiveRegulationOfGeneExpression"},{"id":"E24","span":{"begin":1369,"end":1379},"obj":"PositiveRegulation"},{"id":"E25","span":{"begin":1410,"end":1421},"obj":"PositiveRegulation"},{"id":"E26","span":{"begin":1736,"end":1745},"obj":"PositiveRegulation"},{"id":"E27","span":{"begin":1736,"end":1745},"obj":"PositiveRegulation"}],"relations":[{"id":"R1","pred":"hasPart","subj":"T29","obj":"T28"},{"id":"R2","pred":"locatedIn","subj":"T46","obj":"T48"},{"id":"R4","pred":"hasAgent","subj":"T3","obj":"E1"},{"id":"R5","pred":"hasPatient","subj":"T2","obj":"E1"},{"id":"R6","pred":"hasAgent","subj":"T11","obj":"E4"},{"id":"R7","pred":"hasPatient","subj":"T9","obj":"E4"},{"id":"R8","pred":"hasAgent","subj":"T15","obj":"E5"},{"id":"R9","pred":"hasPatient","subj":"T14","obj":"E5"},{"id":"R10","pred":"hasPatient","subj":"T17","obj":"E6"},{"id":"R11","pred":"hasPatient","subj":"T20","obj":"E7"},{"id":"R12","pred":"hasPatient","subj":"T28","obj":"E8"},{"id":"R13","pred":"hasAgent","subj":"T30","obj":"E9"},{"id":"R14","pred":"hasPatient","subj":"T32","obj":"E9"},{"id":"R15","pred":"hasAgent","subj":"E9","obj":"E10"},{"id":"R16","pred":"hasPatient","subj":"T34","obj":"E10"},{"id":"R17","pred":"hasPatient","subj":"T38","obj":"E11"},{"id":"R18","pred":"hasPatient","subj":"T35","obj":"E11"},{"id":"R19","pred":"hasPatient","subj":"T36","obj":"E11"},{"id":"R20","pred":"hasAgent","subj":"E23","obj":"E12"},{"id":"R21","pred":"hasPatient","subj":"T41","obj":"E12"},{"id":"R22","pred":"hasPatient","subj":"T45","obj":"E13"},{"id":"R23","pred":"hasPatient","subj":"T51","obj":"E14"},{"id":"R24","pred":"hasPatient","subj":"T54","obj":"E15"},{"id":"R25","pred":"hasAgent","subj":"T57","obj":"E16"},{"id":"R26","pred":"hasPatient","subj":"T56","obj":"E16"},{"id":"R27","pred":"hasAgent","subj":"T62","obj":"E17"},{"id":"R28","pred":"hasPatient","subj":"T64","obj":"E17"},{"id":"R29","pred":"hasAgent","subj":"T65","obj":"E18"},{"id":"R30","pred":"hasPatient","subj":"T67","obj":"E18"},{"id":"R31","pred":"hasAgent","subj":"T65","obj":"E19"},{"id":"R32","pred":"hasPatient","subj":"T69","obj":"E19"},{"id":"R33","pred":"hasAgent","subj":"T21","obj":"E20"},{"id":"R34","pred":"hasPatient","subj":"T23","obj":"E20"},{"id":"R35","pred":"hasPatient","subj":"T39","obj":"E23"},{"id":"R36","pred":"hasAgent","subj":"T47","obj":"E24"},{"id":"R37","pred":"hasPatient","subj":"T48","obj":"E24"},{"id":"R38","pred":"hasAgent","subj":"T80","obj":"E25"},{"id":"R39","pred":"hasPatient","subj":"T49","obj":"E25"},{"id":"R40","pred":"hasAgent","subj":"T59","obj":"E26"},{"id":"R41","pred":"hasPatient","subj":"T60","obj":"E26"},{"id":"R42","pred":"hasAgent","subj":"T58","obj":"E27"},{"id":"R43","pred":"hasPatient","subj":"T60","obj":"E27"}],"text":"Activation of IkappaB kinase beta by protein kinase C isoforms.\nThe atypical protein kinase C (PKC) isotypes (lambda/iotaPKC and zetaPKC) have been shown to be critically involved in important cell functions such as proliferation and survival. Previous studies have demonstrated that the atypical PKCs are stimulated by tumor necrosis factor alpha (TNF-alpha) and are required for the activation of NF-kappaB by this cytokine through a mechanism that most probably involves the phosphorylation of IkappaB. The inability of these PKC isotypes to directly phosphorylate IkappaB led to the hypothesis that zetaPKC may use a putative IkappaB kinase to functionally inactivate IkappaB. Recently several groups have molecularly characterized and cloned two IkappaB kinases (IKKalpha and IKKbeta) which phosphorylate the residues in the IkappaB molecule that serve to target it for ubiquitination and degradation. In this study we have addressed the possibility that different PKCs may control NF-kappaB through the activation of the IKKs. We report here that alphaPKC as well as the atypical PKCs bind to the IKKs in vitro and in vivo. In addition, overexpression of zetaPKC positively modulates IKKbeta activity but not that of IKKalpha, whereas the transfection of a zetaPKC dominant negative mutant severely impairs the activation of IKKbeta but not IKKalpha in TNF-alpha-stimulated cells. We also show that cell stimulation with phorbol 12-myristate 13-acetate activates IKKbeta, which is entirely dependent on the activity of alphaPKC but not that of the atypical isoforms. In contrast, the inhibition of alphaPKC does not affect the activation of IKKbeta by TNF-alpha. Interestingly, recombinant active zetaPKC and alphaPKC are able to stimulate in vitro the activity of IKKbeta but not that of IKKalpha. In addition, evidence is presented here that recombinant zetaPKC directly phosphorylates IKKbeta in vitro, involving Ser177 and Ser181. Collectively, these results demonstrate a critical role for the PKC isoforms in the NF-kappaB pathway at the level of IKKbeta activation and IkappaB degradation."}
PubmedHPO
{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":320,"end":325},"obj":"HP_0002664"}],"text":"Activation of IkappaB kinase beta by protein kinase C isoforms.\nThe atypical protein kinase C (PKC) isotypes (lambda/iotaPKC and zetaPKC) have been shown to be critically involved in important cell functions such as proliferation and survival. Previous studies have demonstrated that the atypical PKCs are stimulated by tumor necrosis factor alpha (TNF-alpha) and are required for the activation of NF-kappaB by this cytokine through a mechanism that most probably involves the phosphorylation of IkappaB. The inability of these PKC isotypes to directly phosphorylate IkappaB led to the hypothesis that zetaPKC may use a putative IkappaB kinase to functionally inactivate IkappaB. Recently several groups have molecularly characterized and cloned two IkappaB kinases (IKKalpha and IKKbeta) which phosphorylate the residues in the IkappaB molecule that serve to target it for ubiquitination and degradation. In this study we have addressed the possibility that different PKCs may control NF-kappaB through the activation of the IKKs. We report here that alphaPKC as well as the atypical PKCs bind to the IKKs in vitro and in vivo. In addition, overexpression of zetaPKC positively modulates IKKbeta activity but not that of IKKalpha, whereas the transfection of a zetaPKC dominant negative mutant severely impairs the activation of IKKbeta but not IKKalpha in TNF-alpha-stimulated cells. We also show that cell stimulation with phorbol 12-myristate 13-acetate activates IKKbeta, which is entirely dependent on the activity of alphaPKC but not that of the atypical isoforms. In contrast, the inhibition of alphaPKC does not affect the activation of IKKbeta by TNF-alpha. Interestingly, recombinant active zetaPKC and alphaPKC are able to stimulate in vitro the activity of IKKbeta but not that of IKKalpha. In addition, evidence is presented here that recombinant zetaPKC directly phosphorylates IKKbeta in vitro, involving Ser177 and Ser181. Collectively, these results demonstrate a critical role for the PKC isoforms in the NF-kappaB pathway at the level of IKKbeta activation and IkappaB degradation."}